Depression
Explore undermethylation, overmethylation, copper imbalance, vitamin D, inflammation, gut health and elevated SAH in different depressive patterns.
Depression articlesDepression, anxiety, ADHD, OCD, insomnia and other mental health conditions are diagnosed primarily by symptoms. Symptoms matter, but they do not always explain why a condition developed, why one medication helped while another failed, or why two people with the same diagnosis respond differently to treatment.
The Walsh Approach adds another question to a symptom-based diagnosis: Which biochemical patterns may be contributing to the symptoms, medication response and long-term course?
Methylation status, copper and zinc balance, pyroluria, elevated SAH, nutrient deficiencies, inflammation, gut dysfunction, hormones, mitochondrial stress and toxic burden may all influence mood, cognition, sleep and behavior. These factors do not replace a psychiatric diagnosis, but they may help explain why people with the same diagnosis respond very differently.
Explore undermethylation, overmethylation, copper imbalance, vitamin D, inflammation, gut health and elevated SAH in different depressive patterns.
Depression articlesReview copper overload, pyroluria, methylation status, stimulant sensitivity, hormones and nutrient deficiencies that may intensify anxiety or panic.
Anxiety and panic articlesConsider dopamine regulation, methylation, zinc, vitamin B6, iron, sleep, diet, learning differences and stimulant response.
ADHD and pediatric assessmentUnderstand how undermethylation, glutamate activity, oxidative stress, copper-zinc balance and medication response may affect intrusive thoughts and compulsions.
OCD articlesExplore methylation, oxidative stress, immune activation, gut dysfunction, nutrient status, folate receptor antibodies and individualized testing.
Autism and undermethylation articlesReview genetic susceptibility, calcium-channel signaling, sleep loss, inflammation, oxidative stress, mitochondrial function and medication safety.
Bipolar disorder guideLearn why stabilization remains essential while methylation, copper-zinc balance, oxidative stress, nutrition, sleep and toxic burden are assessed.
Schizophrenia guideReview anxiety, copper, methylation, cortisol, hormones, blood sugar, inflammation, gut discomfort and medication effects that may interfere with sleep.
Insomnia guideExplore nutrient deficiencies, thyroid function, inflammation, methylation, sleep, vascular risk, mitochondrial function and toxic burden.
Dementia and cognitive decline guideA Walsh biotype is not a psychiatric diagnosis. It is a biochemical pattern that can appear in several conditions. A patient with depression, anxiety, OCD, ADHD or insomnia may therefore share certain laboratory findings while having a very different clinical presentation.
May involve high whole-blood histamine, low methyl availability, perfectionism, obsessive traits, inner tension and altered serotonin or dopamine activity.
Explore undermethylationMay involve low whole-blood histamine, chemical sensitivity, anxiety, sleep disturbance and poor tolerance of methyl donors or serotonergic medication.
Explore overmethylationMay contribute to anxiety, panic, irritability, insomnia, hormonal mood changes and excessive norepinephrine activity.
Explore copper overloadMay involve zinc and vitamin B6 depletion, oxidative vulnerability, social withdrawal, sensory sensitivity and reduced stress tolerance.
Explore pyroluriaMay involve environmental exposure, oxidative stress, impaired clearance, inflammation and interference with methylation.
Explore toxic burdenDirect methylation testing may identify impaired methylation even when homocysteine or genetic testing does not fully explain the symptoms.
Explore SAM and SAHNo single laboratory test diagnoses depression, anxiety, ADHD or another psychiatric condition. Targeted testing may identify biochemical abnormalities that affect neurotransmitter activity, medication response, inflammation, energy production or nutrient treatment.
| Laboratory marker | What it may help evaluate | Related clinical patterns |
|---|---|---|
| Serum copper and ceruloplasmin | Copper transport, binding capacity and calculated non-ceruloplasmin-bound copper. | Anxiety, panic, irritability, postpartum mood symptoms and oxidative stress. |
| Plasma zinc | Mineral balance, antioxidant protection and neurotransmitter-related nutrient pathways. | Copper imbalance, pyroluria, immune function and behavioral symptoms. |
| Whole-blood histamine | A traditional Walsh marker used with symptoms when assessing methylation patterns. | Undermethylation, overmethylation, depression, OCD and medication response. |
| SAM, SAH and SAM-to-SAH ratio | Methyl-donor availability and inhibition of methyltransferase reactions by elevated SAH. | Methylation impairment, toxic burden, creatine demand, cognition and mood. |
| Homocysteine | One-carbon metabolism and aspects of methionine and transsulfuration pathways. | Methylation, B-vitamin status, cardiovascular risk and cognition. |
| Vitamin D and urinary pyrroles | Vitamin D status and specialized assessment of possible pyrrole-related zinc/B6 depletion. | Depression, immunity, pyroluria, stress intolerance and oxidative vulnerability. |
| CBC, CMP and thyroid testing | Anemia, glucose, electrolytes, liver and kidney function, and thyroid-related contributors. | Fatigue, mood changes, cognition and medication safety. |
Digestion, nutrient absorption, dysbiosis, intestinal inflammation, food reactions and microbial metabolites may influence mood and cognition.
Explore gut healthChronic inflammatory signaling may affect energy, sleep, motivation, cognition, neurotransmitter metabolism and treatment response.
Explore inflammationAllergic and mast-cell activity can overlap with anxiety, insomnia, cognitive symptoms, gut problems and histamine-related methylation patterns.
Explore mast cell activationMitochondrial impairment may affect ATP production, oxidative resilience, cognition, fatigue and the energy-dependent production of SAM.
Explore mitochondrial functionKidney buffering, liver metabolism, protein synthesis and elimination pathways may affect nutrient handling, SAH clearance and toxic burden.
Explore kidney and methylationEnvironmental exposure, inflammation and oxidative injury may impair mitochondria, disturb mineral balance and increase methylation demand.
Explore toxic burdenNutrient testing and biochemical treatment are not substitutes for immediate psychiatric stabilization when a person has severe depression, suicidal intent, psychosis, mania, dangerous behavior or an inability to care for basic needs. Medication, hospitalization or urgent intervention may be necessary.
The longer-term goal is to identify correctable abnormalities, improve nutrient and metabolic status, and optimize medication selection when medication remains necessary.
The questionnaire, laboratory panels and physician consultation provide different levels of assessment. The best starting point depends on symptom severity, complexity, medication use and whether useful recent laboratory results are already available.
Nutrient deficiencies may contribute to neurological and psychiatric symptoms, although they are rarely the only possible explanation. Testing, history, medication use and the full clinical picture should be considered together.
Yes. Depression is a clinical syndrome rather than one uniform biochemical state. Different patients may show undermethylation, overmethylation, copper imbalance, inflammation, thyroid dysfunction, nutrient deficiency, medication effects or elevated SAH.
Common testing may include whole-blood histamine, serum copper, ceruloplasmin, plasma zinc, vitamin D, homocysteine, urinary pyrroles, CBC and CMP. SAM and SAH testing may be added when a more direct methylation assessment is needed.
No. Medication may be essential during severe depression, suicide risk, psychosis, mania or dangerous instability. Biochemical testing and nutrient treatment may add useful information, but medication reduction should be gradual and supervised.
Patients uncertain about testing or consultation can begin with the free pre-consultation or a WalshDoc questionnaire to organize symptoms and identify likely testing priorities.
Educational information only. This page does not diagnose a psychiatric or medical disorder. Urgent symptoms, suicidal thoughts, psychosis, mania, severe agitation or risk of harm require immediate conventional medical or psychiatric care.